aod9604 clinical trial doses AOD-9604 Peptide You’re Injecting AOD-9604 WRONG! Doctor

Dosing by body weight category Under 160 pounds (72kg): Start with 300mcg daily

Body composition data from the SURMOUNT-1 DXA substudy showed approximately 75% of weight lost came from fat mass and 25% from lean mass

Youll receive an email with tracking information once your medication ships

Submit your medical intake form to become a patient now

It combines the injection of HCG hormone and a harsh calorie limitation of 500 calories a day to support weight loss

Professor Ngs research contributions to AOD-9604 development include: Synthesis and characterization of the modified C-terminal growth hormone fragment with enhanced stability Design of the tyrosine N-terminal modification to improve peptide stability and half-life Preclinical studies demonstrating lipolytic effects in obese animal models Advancement of the peptide through multiple phases of clinical development Investigation of mechanisms underlying beta-3-adrenergic receptor modulation His work established the foundation for understanding peptide-based approaches to metabolic regulation, though clinical translation ultimately proved unsuccessful